home / stock / aldr / aldr quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $18.88 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 11/28/2019 04:57:55 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-28-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-27-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-26-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-25-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-22-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-21-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-20-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-19-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-18-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-15-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-14-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-13-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-12-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-11-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-08-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-07-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-06-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-05-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-04-2019 |
$ | $N/A | $18.88 | $N/A | $N/A | 0 | 11-01-2019 |
News, Short Squeeze, Breakout and More Instantly...
Alder BioPharmaceuticals Inc. Company Name:
ALDR Stock Symbol:
NASDAQ Market:
Alder BioPharmaceuticals Inc. Website:
Biotech is in the doldrums. The SPDR S&P Biotech ETF declined 18% in the past six months, and money continues to flow out of the sector. While several biotechs managed to IPO in September and October , it's not all roses. ADC Therapeutics pulled its plans to list citing market...
BOTHELL, Wash., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing therapeutic antibodies for the treatment of migraine, today announced dosing of the first patient in a Phase 1 clinical study to evaluate ALD191...
Shares of Alder Biopharmaceuticals (NASDAQ: ALDR) jumped 111% in September, according to data provided by S&P Global Market Intelligence , after the biotech said it will be acquired by Lundbeck. Lundbeck, a fairly large drugmaker in Denmark, is after Alder Pharmaceuticals' migraine m...